Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.35 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397915 | 0.89 | DGKA (0.50) | DGKADNM1HTR2CENPP2TRPV1 | |
| SCHEMBL28390346 | 0.86 | DGKA (0.45) | DGKAADRA2AADRA1ADNM1MAPT | |
| Butane SCHEMBL2238380 | 0.84 | DGKA (0.44) | DGKAADRA2AADRA1ADNM1MAPT | |
| SCHEMBL4004473 | 0.84 | MGLL (0.39) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL2397581 | 0.83 | SMN1; SMN2 (0.49) | SMN1; SMN2POLBALDH1A1 | |
| Ethylene Glycol SCHEMBL5407450 | 0.82 | MGLL (0.38) | DGKAADRA2AADRA1AMAPTBLM | |
| SCHEMBL29025936 | 0.81 | DGKA (0.41) | DGKAADRA2AADRA1ADNM1MAPT | |
| SCHEMBL28392405 | 0.80 | DGKA (0.44) | DGKAADRA2AADRA1ADNM1MAPT | |
| SCHEMBL2240315 | 0.78 | DGKA (0.42) | DGKAADRA2AADRA1ADNM1MAPT | |
| SCHEMBL5707260 | 0.78 | DGKA (0.42) | DGKAADRA2AADRA1ADNM1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160215123-A1 | PHOSPHORUS-CONTAINING THERMOPLASTIC POLYESTER AND PHOSPHORUS-CONTAINING HEAT-SHRINKABLE TUBE MADE THEREFROM | NAN YA PLASTICS CORPORATION (TW) | 2016-07-28 | — | — | US | disclosed |
| CN-104761583-A | METHOD FOR PRODUCING PHOSPHORUS-CONTAINING ALPHA-KETO ACID | MEIJI SEIKA KAISHA | 2015-07-08 | — | — | CN | disclosed |
| US-8017797-B2 | Method for producing phosphorus-containing α-keto acid | MEIJI SEIKA KAISHA LTD. (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20100063313-A1 | METHOD FOR PRODUCING PHOSPHORUS-CONTAINING ALPHA-KETO ACID | MEIJI SEIKA KAISHA LTD., (JP) | 2010-03-11 | — | — | US | disclosed |
| CN-101641363-A | Method for producing phosphorus-containing alpha-keto acid | MEIJI SEIKA KAISHA JP | 2010-02-03 | — | — | CN | disclosed |
| EP-2133356-A1 | PROCESS FOR PRODUCTION OF PHOSPHORUS-CONTAINING -KETO ACID | Meiji Seika Kaisha, Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063313-A1 | METHOD FOR PRODUCING PHOSPHORUS-CONTAINING ALPHA-KETO ACID | PRKAB1, PRKAB2, PLCB1 | DGKA 494/4885ADRA2A 1651/4885ADRA1A 1653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.